User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Oct 21 2014 05:57 IST RSS 2.0
 
1 to 20 of 2,638    
Pharma companies feel law change can weaken ability to provide low-cost drugs 21.10.2014 ET: Pharma
Indian drugmakers are also concerned about a shift in India’s position on IPR, which they say is being keenly watched by many developing countries.
Also found in: [+]
Discount deewane 20.10.2014 HBL: Opinion
LETTERS TO THE EDITOR Send your letters by email to bleditor@thehindu.co.in or by post to ‘Letters to the Editor’, The Hindu Business Line, Kasturi Buildings, 859-860, Anna Salai, Chennai 600002.
Also found in: [+]
US pharma gets a booster shot 19.10.2014 HBL: Opinion
Thanks to the India-US Intellectual Property Working Group. Here’s how — and why this is bad news for India’s poor
Also found in: [+]
Medical charity accuses US of pushing India to ease patent rules 18.10.2014 ET: Pharma
India's stringent rules for obtaining patents and its $12.2-billion generics industry reduce incentives to produce cutting-edge medicines.
Also found in: [+]
Exclusive: NSA reviewing deal between official, ex-spy agency head 18.10.2014 FirstPost: World

WASHINGTON (Reuters) - The U.S. National Security Agency has launched an internal review of a senior official’s part-time work for a private venture started by former NSA director Keith Alexander that raises questions over the blurring of lines between government and business. Under the arrangement, which was confirmed by Alexander and current intelligence officials, NSA's Chief Technical Officer, Patrick Dowd, is allowed to work up to 20 hours a week at IronNet Cybersecurity Inc, the private firm led by Alexander, a retired Army general and his former boss.

The post Exclusive: NSA reviewing deal between official, ex-spy agency head appeared first on Firstpost.

Also found in: [+]
NSA reviewing deal between official, ex-spy agency head 18.10.2014 TOI: The United States
The US National Security Agency has launched an internal review of a senior official’s part-time work for a private venture started by former NSA director Keith Alexander that raises questions over the blurring of lines between government and ...
Also found in: [+]
US complaints about India's IPR regime are bullying attempts 17.10.2014 ET: Opinion
When Modi visited the US, there was a US-India joint statement that spoke of an annual high-level Intellectual Property Working Group as part of the US-India Trade Policy Forum.
Also found in: [+]
DIPP defers decision on issuance of compulsory licence for cancer drug Dasatinib 16.10.2014 ET: Pharma
“DIPP has sought further information to justify the issuance of a CL under Section 92 of Indian Patents Act,” said an official privy to the matter."
Also found in: [+]
‘India loses out as arbitration seat’ 16.10.2014 Chennai News, Tamil News, Chennai City News, Tamil Nadu News | TOI City News
India is not seen as a preferred seat for international arbitration because of excessive judicial intervention, inordinate delay, high costs and difficulty in enforcing arbitration awards, said Justice A P Shah, chairman, Law Commission of ...
Also found in: [+]
Buzz off, says Delhi to US Trade Representative 15.10.2014 News
The Government of India has told American authorities that it will not cooperate with the out-of-cycle review
Also found in: [+]
Don't dilute patent law, IPR regime: CPI-M 14.10.2014 New Kerala: India News
New Delhi, Oct 14 : The CPI-M Tuesday asked the government not to dilute the existing patent law and IPR regime, saying they had kept prices of drugs down in India.
Also found in: [+]
Don't dilute patent law, IPR regime: CPI-M 14.10.2014 All News-IANS Stories
The CPI-M Tuesday asked the government not to dilute the existing patent law and IPR regime, saying they had kept prices of drugs down in India.
Also found in: [+]
US to launch fresh review of India's patent regime 14.10.2014 ET: Policy
US Trade Representative has launched a fresh offensive against India's intellectual property rights regime, a move that may hamper bilateral dialogue with US.
Also found in: [+]
An old policy Modi must hold on to 14.10.2014 India Together

The government’s clarification on the Indo-US joint statement on Intellectual Property Rights issued during Modi’s visit to the United States highlights the imperative of maintaining India’s original stance on patent laws and refusal to yield to US demands made in its Special 301 Report. Shambhu Ghatak has more.

Also found in: [+]
Pharma patent regime may get stricter, say experts 14.10.2014 DNA: Bangalore
Pharma patent regime may get stricter, say experts
Also found in: [+]
US to launch fresh review of India's patent regime 14.10.2014 TOI: India Business
An OCR is a second stage of the Special 301 action and being an extreme measure, the US authorities can impose sanctions after putting the country in the "priority foreign watch" category.
Also found in: [+]
Symposium stresses need to set up patent office 13.10.2014 The Assam Tribune
Symposium stresses need to set up patent office
Also found in: [+]
Proof of Modi's pudding will be in the eating 11.10.2014 New Kerala: India News
By Seema Sirohi, Washington, Oct. 11 : India and the United States need a few "early wins" to prove that there is substance in the promises made by Prime Minister Narendra Modi during his visit to encourage American investments.
Also found in: [+]
For the greater common good 9.10.2014 HBL: Opinion
Harmony between intellectual property rights and the competition law can ensure economic and social welfare
Also found in: [+]
Why did Modi agree to give away India's patent sovereignty to Americans? - Firstpost 8.10.2014
Why did Modi agree to give away India's patent sovereignty to Americans? Firstpost With the hype of his Madison Square Garden show overshadowing everything else, Prime Minister Narendra Modi's US visit was dubbed as a great bilateral victory for India. As the popular consensus went, Modi wowed both the Indian Americans ...
Also found in: [+]
1 to 20 of 2,638